MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$105,380M
Net Income
$614M
Net Profit Margin
0.58%
EPS
$5.15
Unit: Million (M) dollars
Revenue Breakdown
North American Pharmaceutical Se...
Oncology And Multispecialty Segm...
Medical Surgical Solutions Segme...
Prescription Technology Solution...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
105,380
96,295
106,158
103,150
Cost of sales
101,695
92,251
102,473
99,608
Gross profit
3,685
4,044
3,685
3,542
Selling, distribution, general, and administrative expenses
2,264
1,796
2,030
2,074
Claims and litigation charges, net
34
1
0
2
Restructuring, impairment, and related charges, net
136
99
36
63
Total operating expenses
2,366
1,894
2,066
2,135
Operating income
1,319
2,150
1,619
1,407
Other income, net
66
36
74
62
Interest expense
77
61
63
74
Income before income taxes
1,308
2,125
1,630
1,395
Income tax expense
276
270
380
232
Net income
1,032
1,855
1,250
1,163
Net income attributable to noncontrolling interests
418
173
64
53
Net income attributable to mckesson corporation
614
1,682
1,186
1,110
Basic EPS
5.17
13.753
9.63
8.95
Diluted EPS
5.15
13.697
9.59
8.92
Basic Average Shares
118,700,000
122,300,000
123,200,000
124,000,000
Diluted Average Shares
119,200,000
122,800,000
123,700,000
124,400,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
MCK Income Statement Sankey Diagram
Sankey diagram visualizing MCK income statement for the period
North American
Pharmaceutical Segment
$86,773M
Oncology And
Multispecialty Segment
$14,222M
Medical Surgical
Solutions Segment
$2,819M
(4.37%↑ Y/Y)
Prescription Technology
Solutions Segment
$1,566M
(9.21%↑ Y/Y)
Revenues
$105,380M
(7.72%↑ Y/Y)
Gross profit
$3,685M
(12.38%↑ Y/Y)
Cost of sales
$101,695M
(7.56%↑ Y/Y)
Operating income
$1,319M
(27.32%↑ Y/Y)
Other income, net
$66M
(3.13%↑ Y/Y)
Total operating
expenses
$2,366M
(5.48%↑ Y/Y)
Claims and litigation
charges, net
$34M
Income before income
taxes
$1,308M
(24.45%↑ Y/Y)
Interest expense
$77M
(57.14%↑ Y/Y)
Selling, distribution,
general, and...
$2,264M
(3.10%↑ Y/Y)
Restructuring, impairment, and
related charges, net
$136M
(189.36%↑ Y/Y)
Net income
$1,032M
(24.19%↑ Y/Y)
Income tax expense
$276M
(25.45%↑ Y/Y)
Net income
attributable to mckesson...
$614M
(-21.68%↓ Y/Y)
Net income
attributable to...
$418M
(789.36%↑ Y/Y)
Buy us a coffee
mck_logo_blue-svg
MCKESSON CORP (MCK)
mck_logo_blue-svg
MCKESSON CORP (MCK)